Aberrant regulation of eIF2α is implicated in various diseases. For instance, chronic phosphorylation of eIF2α is observed in several neurodegenerative disorders like Alzheimer's and Parkinson's disease, leading to impaired protein synthesis and neuronal dysfunction. Additionally, some cancers exploit the eIF2α pathway to survive under hypoxic conditions, making it a potential target for therapeutic intervention.
